The Impact of NSAID Use on Dementia Risk: Duration Matters
Swapping Butter for Plant-Based Oils Linked to Lower Risk of Premature Death
Rise in Measles Cases Sparks Interest in Vitamin A Supplements: What Experts Say
Better Heart Health May Lower Risk of Neurodegenerative Diseases
The Potential Benefits of Intermittent Fasting in Reducing Blood Clot Risk
Aspirin May Help Prevent Cancer Spread by Boosting Immune Response
The Dangers of Expired Medication and Safe Disposal Methods
Advances in Stem Cell Treatment for Unilateral Limbal Stem Cell Deficiency (LSCD)
Oranges May Help Lower Depression Risk
July 30,2024
Potential Breakthrough in Obesity Drugs: Targeting Brain Neurons to Avoid Nausea
Nausea is a common side effect of obesity and Type 2 diabetes medications like Ozempic and Wegovy, often leading some users to discontinue their use. However, scientists at the Monell Chemical Senses Center in Philadelphia have discovered a collection of neurons in the brains of mice that may promote weight loss without causing nausea.
The researchers suggest that obesity drug developers should focus on the nucleus tractus solitarius, a crucial brainstem structure that processes taste information. Amber L. Alhadeff, the senior study author and assistant member at Monell, stated, "Developing experimental obesity drugs that selectively activate this population may promote weight loss while avoiding aversive side effects."
Copyright © 2025 Dotcom Africa. All Rights Reserved. Terms of Service | Contact | Advertise with us | About Us